Life Sciences & Health Care Bookmark has been added
Life Sciences & Health Care
Navigating what’s next
The life sciences and health care industry is being disrupted and reshaped by emerging technologies, new data sources, nontraditional market entrants, and increasing consumer demands. What new developments could emerge in 2020 that will continue to shape the future of health? Participants will analyze trends and issues that are on the horizon in 2020 and beyond, and they will assess what such changes might mean for health care and life sciences companies.
While digital technology is widely available to the general population, it generally has not made its way into clinical trials. That's all changing. Participants will explore how virtual clinical trials are changing the way research is conducted and identify ways they ultimately benefit the patient.
Life sciences and health care C-suite executives are navigating a new normal focused on better outcomes and more value. Are organizations prepared to embrace enterprisewide digital strategies, and, looking toward 2040, are leadership teams prepared for what is on the horizon? Participants will assess different ways for life sciences and health care leaders to think about investments and strategies today to prepare for the future of health.
By 2040, the health ecosystem will be redefined to focus on well-being and prevention for all socioeconomic classes. What could health care spending as a percentage of GDP look like by 2040 and how could spending shift toward nontraditional health care services? Participants will identify potential areas of revenue shifts and determine how they could affect incumbent and disruptive players in 2040.
Radically interoperable data and the future of health
November 14, 2019
Health care transformation: Bringing health back into communities
October 15, 2019
Taking a cyber everywhere approach for life sciences and health care
September 26, 2019